Form 4: Orchestra BioMed CFO Sells Shares to Cover Tax Obligations

Orchestra BioMed's Chief Financial Officer, Andrew Taylor, sold 34,403 shares to cover tax obligations related to vesting restricted stock units.

Summary

• Andrew Taylor, the Chief Financial Officer of Orchestra BioMed Holdings, Inc., sold 34,403 shares of common stock on December 12, 2024.
• The sale was executed at a price of $5.03 per share.
• This transaction was to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following the transaction, Mr. Taylor directly owns 343,960 shares of Orchestra BioMed common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, not indicative of positive or negative sentiment.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

• Form 4 filings are standard practice for corporate insiders and are required by the SEC.
• The sale of shares to cover tax obligations is a common practice among executives at publicly traded companies.
• The number of shares sold is relatively small compared to the total number of shares owned by the CFO.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale for tax purposes.

Key Dates

Keywords

Orchestra BioMed, Andrew Taylor, Chief Financial Officer, stock sale, tax obligations, restricted stock units, Form 4, insider trading